1. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep 1999;22:Suppl 2. S379-S385.
2. Avidan AY. Insomnia in the geriatric patient. Clin Cornerstone 2003;5:51-60.
3. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA 1989;262:1479-1484.
5. Parthasarathy S, Vasquez MM, Halonen M, Bootzin R, Quan SF, Martinez FD, Guerra S. Persistent insomnia is associated with mortality risk. Am J Med 2015;128:268-275.
10. Chong Y, Fryer CD, Gu Q. Prescription sleep aid use among adults: United States, 2005-2010. NCHS Data Brief 2013;(127):1-8.
12. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999;281:991-999.
14. Riba J, Rodriguez-Fornells A, Munte TF, Barbanoj MJ. A neurophysiological study of the detrimental effects of alprazolam on human action monitoring. Brain Res Cogn Brain Res 2005;25:554-565.
15. Chang CM, Wu EC, Chen CY, Wu KY, Liang HY, Chau YL, Wu CS, Lin KM, Tsai HJ. Psychotropic drugs and risk of motor vehicle accidents: a population-based case-control study. Br J Clin Pharmacol 2013;75:1125-1133.
16. Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Morland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008;9:818-822.
17. Farkas RH, Unger EF, Temple R. Zolpidem and driving impairment: identifying persons at risk. N Engl J Med 2013;369:689-691.
18. Kuehn BM. FDA warning: Driving may be impaired the morning following sleeping pill use. JAMA 2013;309:645-646.
19. Lai MM, Lin CC, Lin CC, Liu CS, Li TC, Kao CH. Long-term use of zolpidem increases the risk of major injury: a population-based cohort study. Mayo Clin Proc 2014;89:589-594.
20. Nzwalo H, Ferreira L, Peralta R, Bentes C. Sleep-related eating disorder secondary to zolpidem. BMJ Case Rep 2013;02. 21. [Epub]. 10.1136/bcr-2012-008003.
21. Auger RR. Sleep-related eating disorders. Psychiatry (Edgmont) 2006;3:64-70.
25. Shah C, Sharma TR, Kablinger A. Controversies in the use of second generation antipsychotics as sleep agent. Pharmacol Res 2014;79:1-8.
26. Sivertsen B, Omvik S, Pallesen S, Bjorvatn B, Havik OE, Kvale G, Nielsen GH, Nordhus IH. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 2006;295:2851-2858.
27. Morin CM. Insomnia: psychological assessment and management. New York: Guilford Press; 1993.
28. Bootzin RR, Nicassio P. Behavioral treatments for insomnia. In: Hersen M, Eisler RH, Miller PM, editor. Progress in behavior modification. New York: Academic Press; 1978. p. 1-47.
29. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep 1987;10:45-56.
30. Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med 2004;164:1888-1896.